Weiming Duan

997 total citations
39 papers, 819 citations indexed

About

Weiming Duan is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Weiming Duan has authored 39 papers receiving a total of 819 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Oncology and 11 papers in Cancer Research. Recurrent topics in Weiming Duan's work include PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Weiming Duan is often cited by papers focused on PI3K/AKT/mTOR signaling in cancer (8 papers), Chronic Lymphocytic Leukemia Research (7 papers) and Inflammatory Biomarkers in Disease Prognosis (6 papers). Weiming Duan collaborates with scholars based in China, Taiwan and United States. Weiming Duan's co-authors include Kai Chen, Minhang Xin, Mengyao Wu, Min Tao, Wei Li, Liu‐Mei Shou, Yixiang Mao, Fei‐Ran Gong, San‐Qi Zhang and Min Tao and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Cancer and European Journal of Medicinal Chemistry.

In The Last Decade

Weiming Duan

38 papers receiving 811 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiming Duan China 16 406 328 175 151 146 39 819
Eric C. McGary United States 15 628 1.5× 480 1.5× 205 1.2× 143 0.9× 134 0.9× 22 1.1k
Alok R. Singh United States 16 494 1.2× 216 0.7× 177 1.0× 74 0.5× 197 1.3× 25 858
Vanessa Baeriswyl Switzerland 12 728 1.8× 452 1.4× 190 1.1× 73 0.5× 150 1.0× 14 1.1k
Miriam Redrado Spain 20 544 1.3× 518 1.6× 270 1.5× 177 1.2× 233 1.6× 39 1.1k
Sonali Joshi United States 15 465 1.1× 272 0.8× 95 0.5× 56 0.4× 275 1.9× 29 801
Divis Khaira United States 8 378 0.9× 393 1.2× 81 0.5× 101 0.7× 239 1.6× 8 784
Anna D. Staniszewska United Kingdom 12 486 1.2× 462 1.4× 172 1.0× 248 1.6× 206 1.4× 30 984
Hui Lyu China 16 641 1.6× 469 1.4× 282 1.6× 128 0.8× 69 0.5× 33 998
Manikandan Periyasamy United Kingdom 16 767 1.9× 463 1.4× 344 2.0× 206 1.4× 71 0.5× 19 1.2k
Songbo Qiu United States 15 483 1.2× 362 1.1× 271 1.5× 123 0.8× 105 0.7× 26 872

Countries citing papers authored by Weiming Duan

Since Specialization
Citations

This map shows the geographic impact of Weiming Duan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiming Duan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiming Duan more than expected).

Fields of papers citing papers by Weiming Duan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiming Duan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiming Duan. The network helps show where Weiming Duan may publish in the future.

Co-authorship network of co-authors of Weiming Duan

This figure shows the co-authorship network connecting the top 25 collaborators of Weiming Duan. A scholar is included among the top collaborators of Weiming Duan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiming Duan. Weiming Duan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lu, Yujie, Lian Lian, Xiaoming Shen, et al.. (2021). A bioinformatics analysis to evaluate the prognostic value of stemness-related genes in gastric cancer. Translational Cancer Research. 10(1). 174–183. 1 indexed citations
2.
Yu, Yang, Rong Deng, Xuming Wang, et al.. (2021). The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review. Annals of Translational Medicine. 9(22). 1703–1703. 12 indexed citations
3.
Duan, Weiming, et al.. (2021). Establishment and validation of a novel predictive model to quantify the risk of bone metastasis in patients with prostate cancer. Translational Andrology and Urology. 10(1). 310–325. 7 indexed citations
4.
Yuan, Yihang, et al.. (2020). A novel nomogram based on SEER database for the prediction of liver metastasis in patients with small-cell lung cancer. Annals of Palliative Medicine. 9(5). 3123–3137. 10 indexed citations
5.
Lu, Yujie, Wen‐Jie Wang, Min Jiang, et al.. (2019). Prognostic values of platelet-associated indicators in advanced breast cancer. Translational Cancer Research. 8(4). 1326–1335. 1 indexed citations
6.
Zhang, San‐Qi, Yifan Feng, Jin Wang, et al.. (2019). Alkylsulfonamide-containing quinazoline derivatives as potent and orally bioavailable PI3Ks inhibitors. Bioorganic & Medicinal Chemistry. 27(20). 114930–114930. 15 indexed citations
7.
Lu, Yujie, Wen‐Jie Wang, Min Jiang, et al.. (2019). Prognostic values of platelet-associated indicators in advanced breast cancer. Translational Cancer Research. 8(4). 1326–1335. 7 indexed citations
8.
Feng, Yifan, et al.. (2019). Synthesis and biological evaluation of 4-(piperid-3-yl)amino substituted 6-pyridylquinazolines as potent PI3Kδ inhibitors. Bioorganic & Medicinal Chemistry. 27(19). 115035–115035. 15 indexed citations
9.
Xin, Minhang, Weiming Duan, Yifan Feng, et al.. (2018). Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitors. Bioorganic & Medicinal Chemistry. 26(8). 2028–2040. 25 indexed citations
10.
Wu, Xiao Yu, Mengyao Wu, Min Jiang, et al.. (2017). TNF-α sensitizes chemotherapy and radiotherapy against breast cancer cells. Cancer Cell International. 17(1). 13–13. 61 indexed citations
11.
Li, Wei, Rongrui Liang, Chong Zhou, et al.. (2015). The association between expressions of Ras and CD68 in the angiogenesis of breast cancers. Cancer Cell International. 15(1). 17–17. 15 indexed citations
12.
Li, Wei, Mengyao Wu, Rongrui Liang, et al.. (2015). FH535 inhibited metastasis and growth of pancreatic cancer cells. OncoTargets and Therapy. 8. 1651–1651. 14 indexed citations
13.
Qiu, Hao, Weiming Duan, Jie Shu, et al.. (2015). B3GNT2, a Polylactosamine Synthase, Regulates Glycosylation of EGFR in H7721 Human Hepatocellular Carcinoma Cells. Asian Pacific Journal of Cancer Prevention. 15(24). 10875–10878. 5 indexed citations
14.
Shen, Meng, Weiming Duan, Mengyao Wu, et al.. (2015). Participation of autophagy in the cytotoxicity against breast cancer cells by cisplatin. Oncology Reports. 34(1). 359–367. 30 indexed citations
15.
Chen, Kai, Liu‐Mei Shou, Fang Lin, et al.. (2014). Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells. Anti-Cancer Drugs. 25(6). 652–662. 83 indexed citations
16.
Xie, Xin, Mengyao Wu, Liu‐Mei Shou, et al.. (2014). Tamoxifen enhances the anticancer effect of cantharidin and norcantharidin in pancreatic cancer cell lines through inhibition of the protein kinase C signaling pathway. Oncology Letters. 9(2). 837–844. 23 indexed citations
17.
Duan, Weiming, et al.. (2013). Ectopic expression of miR-34a enhances radiosensitivity of non-small cell lung cancer cells, partly by suppressing the LyGDI signaling pathway. Journal of Radiation Research. 54(4). 611–619. 54 indexed citations
18.
Lian, Lian, Wei Li, Zhenyu Li, et al.. (2012). Inhibition of MCF-7 breast cancer cell-induced platelet aggregation using a combination of antiplatelet drugs. Oncology Letters. 5(2). 675–680. 47 indexed citations
19.
Li, Wei, Zheng Chen, Fei‐Ran Gong, et al.. (2011). Growth of the pancreatic cancer cell line PANC-1 is inhibited by protein phosphatase 2A inhibitors through overactivation of the c-Jun N-terminal kinase pathway. European Journal of Cancer. 47(17). 2654–2664. 35 indexed citations
20.
Duan, Weiming, et al.. (2009). Expressions of c-erbB-2, ER, PR and their prognostic correlation in premenopausal and postmenopausal patients with breast cancer.. Zhongliu fangzhi yanjiu. 36(8). 666–668. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric C. McGary Breakdown of academic impact, for papers by Alok R. Singh Breakdown of academic impact, for papers by Vanessa Baeriswyl Breakdown of academic impact, for papers by Miriam Redrado Breakdown of academic impact, for papers by Sonali Joshi Breakdown of academic impact, for papers by Divis Khaira Breakdown of academic impact, for papers by Anna D. Staniszewska Breakdown of academic impact, for papers by Hui Lyu Breakdown of academic impact, for papers by Manikandan Periyasamy Breakdown of academic impact, for papers by Songbo Qiu
Rankless by CCL
2026